Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2010-022739-13Phase 4Active
Phase 4 trial of rocuronium, Sugammadex, succinylcholine and atropine in mental disorder (2 arms), sponsored by Hospital de la Santa Creu i Sant Pau Research Institute. Primary endpoint: Hemodynamic impact of electroconvulsive therapy. Started Oct 2010; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2010-022739-13.